 |
| Doxorubicin, a drug against mesothelioma cancer, could lead to heart failure. |
Researchers at the University of Texas discovered the reason
behind the cardiotoxity of Doxorubicin, a platinum-based drug used to combat mesothelioma,
and certain types of cancer. According to Mesothelioma Help, the drug was discovered to cause heart failure in
some patients. The researchers said that
their findings will help improve cancer care since it will lead to developing
new, heart-friendly drugs to treat mesothelioma.
No comments:
Post a Comment